ConductScience.org, home

Paper975042

Selective lethal effect of supranormal temperatures on human neoplastic cells.

Giovanella BC and 2 others. Cancer Res, 1976. Cited by 183 papers, by iCite.

Cite this record

ConductScience Library. Selective lethal effect of supranormal temperatures on human neoplastic cells. Papers, record 975042. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/975042

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Selective lethal effect of supranormal temperatures on human neoplastic cells.
PubMed
Journal
Cancer Res
PubMed
Year
1976
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
183
iCite
Relative citation ratio, by iCite
6.35
iCite
Revised in PubMed
2014-11-20
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Giovanella BCB C
2Stehlin JS JrJ S
3Morgan ACA C

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hot TemperatureMajor topic
NeoplasmsMajor topic
Carcinoma
Cell Division
Cell Line
Culture Techniques
Epithelial Cells
Epithelium
Female
Fibroblasts
Fibrosarcoma
Humans
Melanocytes
Melanoma
Teratoma
Time Factors

Source PubMed

Download CSV of topics

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 183 citations.

PMIDTitleJournalYearIn PapersSource
41708120Present and future of cytoreductive surgery and hyperthermic intrathoracic chemotherapy for pleural metastases: a narrative review.Eur Respir Rev2026https://conductscience.org/library/papers/41708120PubMed
35292180Hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin induces distinct transcriptomic changes in ovarian tumor and normal tissues.Gynecol Oncol2022https://conductscience.org/library/papers/35292180PubMed
34387765PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 Trial.Ann Surg Oncol2022https://conductscience.org/library/papers/34387765PubMed
31446580In vitro anti-tumor effect of low-power laser irradiation (LPLI) on gastroenterological carcinoma cells.Lasers Med Sci2020https://conductscience.org/library/papers/31446580PubMed
30249527It's time to warm up to hyperthermic intraperitoneal chemotherapy for patients with ovarian cancer.Gynecol Oncol2018https://conductscience.org/library/papers/30249527PubMed
29425952Safety of Therapeutic Fever Induction in Cancer Patients Using Approved PAMP Drugs.Transl Oncol2018https://conductscience.org/library/papers/29425952PubMed
28092994Current status and future prospects of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) clinical trials in ovarian cancer.Int J Hyperthermia2017https://conductscience.org/library/papers/28092994PubMed
27207233Coley's Lessons Remembered: Augmenting Mistletoe Therapy.Integr Cancer Ther2016https://conductscience.org/library/papers/27207233PubMed
25708800Radical surgery in ovarian cancer.Curr Oncol Rep2015https://conductscience.org/library/papers/25708800PubMed
21696631
Sodium arsenite and hyperthermia modulate cisplatin-DNA damage responses and enhance platinum accumulation in murine metastatic ovarian cancer xenograft after hyperthermic intraperitoneal chemotherapy (HIPEC).
J Ovarian Res2011https://conductscience.org/library/papers/21696631PubMed
15573262Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer.World J Surg2004https://conductscience.org/library/papers/15573262PubMed
8426382Preliminary survivorship report on combined intraoperative radiation and hyperthermia treatments for unresectable pancreatic adenocarcinoma.J Natl Med Assoc1993https://conductscience.org/library/papers/8426382PubMed
7421311Regulation of core body temperature during whole body hyperthermia by oesophageal temperature feedback.Med Biol Eng Comput1980https://conductscience.org/library/papers/7421311PubMed
6876999
[Effect of moderate local hyperthermia in combination with chemotherapy with cyclophosphamide or N-nitroso- 1,3-bis(2-chloroethyl)urea(BCNU) on Yoshida sarcoma implanted in the descending colon of rats. 1. Repeated hyperthermia within 8 days and combination of chemotherapy followed by hyperthermia 24 h later].
Langenbecks Arch Chir1983https://conductscience.org/library/papers/6876999PubMed
6871078Thermal radiosensitization in Chinese hamster (V79) and mouse C3H 10T 1/2 cells. The thermotolerance effect.Br J Cancer1983https://conductscience.org/library/papers/6871078PubMed
6685578Renal failure and platinum pharmacokinetics in three patients treated with cis-diamminedichloroplatinum(II) and whole-body hyperthermia.Cancer Chemother Pharmacol1983https://conductscience.org/library/papers/6685578PubMed
6659526Intraperitoneal approach to regional hyperthermia--possible anticancer applications.World J Surg1983https://conductscience.org/library/papers/6659526PubMed
6594154The sensitivity to hyperthermia of human granulocyte/macrophage progenitor cells (CFU-GM) derived from blood or marrow of normal subjects and patients with chronic granulocytic leukaemia.Br J Cancer1984https://conductscience.org/library/papers/6594154PubMed
6503501
[Effect of local moderate hyperthermia in combination with chemotherapy by N-nitroso-1,3-bis-(2-chloroethyl)urea (BCNU) on the descending colon of the rat with transplanted Yoshida sarcoma. 2. Monochemotherapy in combination with subsequent hyperthermia at various time intervals].
Langenbecks Arch Chir1984https://conductscience.org/library/papers/6503501PubMed
6439968
[Effect of local moderate hyperthermia in combination with N-nitroso-1,3-bis-(2-chloroethyl)urea (BCNU) and 5-fluoro-(tetrahydro-2-furyl)uracil (ftorafur) on induced autochthonous colonic cancers in the rat. 3: Polychemotherapy in combination with hyperthermia].
Langenbecks Arch Chir1984https://conductscience.org/library/papers/6439968PubMed

See all 26 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/975042

GET https://conductscience.org/api/papers/v1/975042/cited_by?page=2